• Familial Mediterranean Fever (MEFV) Gene Mutation Analysis
  • Narcolepsy (HLA-DQB1*06:02P) Genotyping
  • Fragile X syndrome
  • Helicobacter pylori Culture with Antimicrobial Susceptibilities
  • Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements, FISH, Tissue
  • Spinocerebellar ataxias
  • Vibrio infection including gastroenteritis
  • Protein S Antigen, Free
  • Testosterone, Bioavailable
  • Lysozyme (Muramidase), Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Medical Test

Reference Ranges
Access to OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection is restricted.
Loading...